Neon Therapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 4 known investors
Biotech
Founders & leadership
RG
Richard Gaynor, M.D.Executive
RA
Robert Ang, M.D.Executive
YA
Yasir Al-WakeelExecutive
EL
Eric LanderNamed on SEC filing
HD
Hugh DowdNamed on SEC filing
Board
CP
Cary Pfeffer, M.D.Board director
RK
SS
Stephen SherwinBoard directorInvestor at Third Rock Ventures
RT
Investors · 4
Reported raises · per SEC filings
Form D private placements$106M disclosed across 1 round · 2016
▶$106MraisedDec 2017 · 25 investors · BiotechnologyRule 506(b)
▶$106MraisedDec 2017 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard Gaynor, M.D.Executive Officer
- Cary Pfeffer, M.D.Director
- Robert KamenDirector
- Eric LanderDirector
- Robert Ang, M.D.Executive Officer
- Yasir Al-WakeelExecutive Officer
- Stephen SherwinDirector
- Hugh DowdExecutive Officer, Director
- Robert TepperDirector
- Offering amount
- $106M
- Amount sold
- $106M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Neon Therapeutics's investors?
- Neon Therapeutics's investors include Nextech Invest, Sofinnova Ventures, Clal Biotechnology Industries, Third Rock Ventures.
- How much funding has Neon Therapeutics raised?
- Neon Therapeutics has disclosed $106M raised across 1 round.
- Where is Neon Therapeutics headquartered?
- Neon Therapeutics is headquartered in Cambridge, US.